Impact of the COVID-19 pandemic on antidepressant prescribing with a focus on people with learning disability and autism: an interrupted time series analysis in England using OpenSAFELY-TPP
Open Access
- 28 April 2025
- journal article
- Published by BMJ in BMJ Mental Health
- Vol. 28 (1) , e301378
Abstract
Background: COVID-19 restrictions led to increased reports of depressive symptoms in the general population and impacted health and social care services. We explored whether these changes affected antidepressant prescribing trends in the general population and those with learning disability or autism. Methods: With the approval of NHS England, we used >24 million patients’ primary care data from the OpenSAFELY-TPP platform. We used interrupted time series analysis to quantify trends in those prescribed and newly prescribed an antidepressant across key demographic and clinical subgroups, comparing pre-COVID-19 (January 2018–February 2020), COVID-19 restrictions (March 2020–February 2021) and recovery (March 2021–December 2022) periods. Results: Prior to COVID-19 restrictions, antidepressant prescribing was increasing in the general population and in those with learning disability or autism. We did not find evidence that the pandemic was associated with a change in antidepressant prescribing trend in the general population (relative risk (RR) 1.00 (95% CI 0.97 to 1.02)), in those with autism (RR 0.99 (95% CI 0.97 to 1.01)) or in those with learning disability (RR 0.98 (95% CI 0.96 to 1.00)). New prescribing post restrictions was 13% and 12% below expected had COVID-19 not happened in both the general population and those with autism (RR 0.87 (95% CI 0.83 to 0.93), RR 0.88 (95% CI 0.83 to 0.92)), but not learning disability (RR 0.96 (95% CI 0.87 to 1.05)). Conclusions and implications: In this England study, we did not see an impact of COVID-19 on overall antidepressant prescribing, although unique trends were noted, such as trends in new antidepressant prescriptions which increased in care homes over the pandemic and decreased in the general population and those with autism since recovery.Keywords
All Related Versions
Funding Information
- Medical Research Council (MC_PC_20059)
- Medical Research Council (MR/V015737/1)
- Medical Research Council (MR/W016729/1)
- Health Data Research UK (HDRUK2021.000)
- Wellcome Trust (222097/Z/20/Z)
This publication has 17 references indexed in Scilit:
- Politicians, experts, and patient representatives call for the UK government to reverse the rate of antidepressant prescribingBMJ, 2023
- Impact of the COVID-19 pandemic on antipsychotic prescribing in individuals with autism, dementia, learning disability, serious mental illness or living in a care home: a federated analysis of 59 million patients’ primary care records in situ using OpenSAFELYBMJ Mental Health, 2023
- Changes to healthcare utilisation and symptoms for common mental health problems over the first 21 months of the COVID-19 pandemic: parallel analyses of electronic health records and survey data in EnglandThe Lancet Regional Health - Europe, 2023
- Effect size quantification for interrupted time series analysis: implementation in R and analysis for Covid-19 researchEmerging Themes in Epidemiology, 2022
- Increased incident rates of antidepressant use during the COVID-19 pandemic: interrupted time-series analysis of a nationally representative samplePsychological Medicine, 2022
- Comparison of Medication Prescribing Before and After the COVID-19 Pandemic Among Nursing Home Residents in Ontario, CanadaJAMA Network Open, 2021
- The effects of COVID-19 restrictions on physical activity and mental health of children and young adults with physical and/or intellectual disabilitiesDisability and Health Journal, 2021
- Indirect acute effects of the COVID-19 pandemic on physical and mental health in the UK: a population-based studyThe Lancet Digital Health, 2021
- Effects of the COVID-19 pandemic on primary care-recorded mental illness and self-harm episodes in the UK: a population-based cohort studyThe Lancet Public Health, 2021
- Interrupted time series analysis in drug utilization research is increasing: systematic review and recommendationsJournal of Clinical Epidemiology, 2015